Chemomab Therapeutics (2QV) Q2 2024 Earnings Report
DE:2QV Q2 2024 EPS Results
- Actual EPS
- -EUR 0.05
- Consensus EPS
- -EUR 0.04
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.13
DE:2QV Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/21/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 21, 2024
DE:2QV Upcoming Earnings
Chemomab Therapeutics's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2QV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | 0.00- | -0.01 | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | -0.13-0.00 | -0.01 | 81.25% (+0.01) | |
| May 14, 2026 | 2026 (Q1) | 0.00-0.00 | -0.03 | 89.29% (+0.02) | |
| Mar 19, 2026 | 2025 (Q4) | -0.04-0.00 | -0.03 | 90.63% (+0.03) | |
| Nov 20, 2025 | 2025 (Q3) | -0.04-0.01 | -0.04 | 60.00% (+0.02) | |
| Aug 14, 2025 | 2025 (Q2) | -0.04-0.01 | -0.05 | 69.23% (+0.03) | |
| May 15, 2025 | 2025 (Q1) | -0.04-0.03 | -0.05 | 50.00% (+0.03) | |
| Mar 03, 2025 | 2024 (Q4) | -0.04-0.03 | -0.05 | 38.46% (+0.02) | |
| Nov 14, 2024 | 2024 (Q3) | -0.04-0.04 | -0.06 | 41.18% (+0.03) | |
| Aug 21, 2024 | 2024 (Q2) | -0.04-0.05 | -0.13 | 63.89% (+0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
